GeneDx Holdings Corp. - Common Stock (WGS)

CUSIP: 81663L200

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class
Equity / Common Stock
Total 13F shares
30,995,113
Total 13F value
$4,027,985,373
Holder snapshot 6 visible 7 signals
Share change
+711,836
Put/Call ratio
108%
SEC-reported price per share
$130.06
Number of holders
286
Value change
+$108,145,320
Number of buys
142
Open additional details 1 more signal available
Number of sells
140
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
28,736,767

Security key

81663L200

Report period

Q4 2025

Institutions

286

Top holders

10

WGS full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 GeneDx Holdings Corp. SEC filings GeneDx Holdings Corp. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of WGS - GeneDx Holdings Corp. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
CMLS Holdings LLC
Disclosed value leader
CMLS Holdings LLC
Comparable rows
15/15
Latest evidence
24 Nov 2025
13D/G 3/4/5 13F Lead comparable stake: 12% 13D/G row: CMLS Holdings LLC Showing 1-6 of 15 holder rows.

Quick read

CMLS Holdings LLC leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens CMLS Holdings LLC's linked filing trail.
Comparable ownership Top 5
CMLS Holdings LLC 12%
ICAHN SCHOOL OF MEDICINE AT MOUNT... 4.9%
WILLIAM BLAIR INVESTMENT MANAGEME... 4.3%
GOLDMAN SACHS GROUP INC 3.9%
SUMMIT PARTNERS PUBLIC ASSET MANA... 3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
CMLS Holdings LLC
13D/G
Keith A. Meister
13D/G
12%
$375,826,799
3,630,826 shares
 -$48,159,994 22 Aug 2025
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
3/4/5 13D/G
10%+ Owner
3/4/5 13D/G
4.9%
from 13D/G
$192,487,561
2,719,692 shares
 — 15 Nov 2024
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
13D/G 13F
Company
13D/G 13F
4.3%
$133,132,271
1,235,681 shares
 -$42,634,981 30 Sep 2025
GOLDMAN SACHS GROUP INC
13F 13D/G
Company · THE GOLDMAN SACHS GROUP, INC.
13F 13D/G
3.9%
from 13D/G
$125,859,714
1,168,180 shares
 — 30 Sep 2025
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC
13F 13D/G
Company
13F 13D/G
3%
from 13D/G
$88,731,109
823,567 shares
 — 30 Sep 2025
FMR LLC
13F 13D/G
Company
13F 13D/G
0.6%
from 13D/G
$54,226,598
503,309 shares
 — 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
286
Shares
30,995,113
Rows available
286
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
265
Q4 2025 holders
286
Holder diff
21
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .